Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 4 (2007), Issue 3 (March)

1. HLA-A0201 positive pancreatic cell lines: new findings and discrepancies.
   Cancer Immunol Immunother, 56(5): 719-24. [Abstract] [Full-text]
2. Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients.
   J Surg Oncol, 95(4): 304-10. [Abstract] [Full-text]
3. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
   J Surg Oncol, 95(4): 286-90. [Abstract] [Full-text]
4. Cystic pancreatic tumors (CPT): predictors of malignant behavior.
   J Surg Oncol, 95(3): 221-8. [Abstract] [Full-text]
5. Major pancreatic resections for suspected cancer in a community-based teaching hospital: lessons learned.
   J Surg Oncol, 95(3): 201-6. [Abstract] [Full-text]
6. Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes.
   J Surg Oncol, 95(4): 332-6. [Abstract] [Full-text]
7. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
   Int J Radiat Oncol Biol Phys, 67(4): 1027-36. [Abstract] [Full-text]
8. Glycemic load, glycemic index, and carbohydrate intake in relation to pancreatic cancer risk in a large US cohort.
   Cancer Causes Control, 18(3): 287-94. [Abstract] [Full-text]
9. Thymosinalpha1 stimulates cell proliferation by activating ERK1/2, JNK, and increasing cytokine secretion in human pancreatic cancer cells.
   Cancer Lett, 248(1): 58-67. [Abstract] [Full-text]
10. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies.
    Int J Cancer, 120(9): 1993-8. [Abstract] [Full-text]
11. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
    J Surg Res, 138(2): 163-9. [Abstract] [Full-text]
12. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
    Int J Cancer, 120(8): 1634-40. [Abstract] [Full-text]
13. Effects of base excision repair gene polymorphisms on pancreatic cancer survival.
    Int J Cancer, 120(8): 1748-54. [Abstract] [Full-text]
14. Antitumor activity of ALK1 in pancreatic carcinoma cells.
    Int J Cancer, 120(8): 1641-51. [Abstract] [Full-text]
15. Molecular diagnostic testing as an adjunct to morphologic evaluation of pancreatic ductal system brushings: potential augmentation for diagnostic sensitivity.
    Diagn Cytopathol, 35(4): 218-24. [Abstract] [Full-text]
16. Solid-pseudopapillary tumor: a report of three cases in adult males diagnosed utilizing three different modalities.
    Diagn Cytopathol, 35(4): 234-8. [Abstract] [Full-text]
17. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer.
    Glycobiology, 17(4): 388-400. [Abstract] [Full-text]
18. Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth.
    Cancer Res, 67(6): 2712-9. [Abstract] [Full-text]
19. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.
    Cancer Res, 67(6): 2666-75. [Abstract] [Full-text]
20. Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer.
    Cancer Res, 67(6): 2568-76. [Abstract] [Full-text]
21. Outcomes analysis of laparoscopic resection of pancreatic neoplasms.
    Surg Endosc, 21(4): 579-86. [Abstract] [Full-text]
22. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
    Bone, 40(4): 1166-71. [Abstract] [Full-text]
23. Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial).
    BMC Surg, 7: 3. [Abstract] [Full-text]
24. Surgical treatment of pancreatic endocrine neoplasms.
    Am J Surg, 193(4): 460-5. [Abstract] [Full-text]
25. Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
    Expert Opin Investig Drugs, 16(4): 467-76. [Abstract] [Full-text]
26. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
    Br J Cancer, 96(6): 993-1000. [Abstract] [Full-text]
27. Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer.
    Surgery, 141(4): 464-9. [Abstract] [Full-text]
28. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.
    Cancer Lett, 249(2): 242-8. [Abstract] [Full-text]
29. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins.
    Cancer Lett, 249(2): 198-208. [Abstract] [Full-text]
30. Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
    Ann Oncol, 18(4): 745-51. [Abstract] [Full-text]
31. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.
    Oncogene, 26(14): 2082-94. [Abstract] [Full-text]
32. Surgical approach to insulinomas: are pre-operative localisation tests necessary?
    Ann R Coll Surg Engl, 89(3): 212-7. [Abstract] [Full-text]
33. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
    Histopathology, 50(5): 597-606. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.